Comparison of Continuous Feeding and Sequential Feeding on Gut Microbiota and Metabolomics in Critically Ill Patients
Launched by QINGDAO UNIVERSITY · Jun 21, 2020
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Nutrition is an important part of therapy for critically ill patients. Continuous feeding is the most popular enteral feeding mode in the ICU because of its lower nursing burden and theoretically better intestinal toleration. However, continuous feeding is nonphysiological. In our opinion, feeding mode should be changed according to gastrointestinal function and disease progression; one singe feeding mode is not always suitable for critically ill patients. We proposed a feeding mode called sequential feeding, as it utilizes a combination of continuous feeding in the beginning, time-restrict...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ●Patients newly admitted to the ICU and fed through gastric tubes
- Exclusion Criteria:
- • Patients with the ability to eat orally at admission
- • Patients with diabetes or gastrointestinal disease
- • Patients who are unable to tolerate enteral feeding
- • An estimated feeding time of less than 7 days
About Qingdao University
Qingdao University is a prominent research institution located in Qingdao, China, dedicated to advancing medical science through innovative clinical trials. With a commitment to enhancing public health, the university conducts rigorous clinical research across various therapeutic areas, leveraging its state-of-the-art facilities and a multidisciplinary team of experts. By fostering collaborations with national and international partners, Qingdao University aims to translate scientific discoveries into effective treatments, contributing to the global body of medical knowledge and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Qingdao, Shandong, China
Patients applied
Trial Officials
Bo Yao, phD
Principal Investigator
The affiliated hospital of Qingdao
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials